Stock ASTERDM ASTER DM HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aster DM Healthcare Limited

Equities

ASTERDM

INE914M01019

Healthcare Facilities & Services

Market Closed - NSE India S.E.
Other stock markets
 07:43:51 2024-05-31 am EDT 		5-day change 1st Jan Change
364 INR +2.10% Intraday chart for Aster DM Healthcare Limited -0.53% -11.19%
May. 29 Transcript : Aster DM Healthcare Limited, Q4 2024 Earnings Call, May 29, 2024
May. 28 Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24 CI

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 77,310 47,243 68,245 98,191 119,695 181,018 - -
Enterprise Value (EV) 1 99,951 70,150 108,913 143,400 172,300 271,457 167,399 164,366
P/E ratio 23.3 x 17.3 x 46.3 x 18.7 x 28.2 x 157 x 11.3 x 35.4 x
Yield - - - - - 0.49% 16.6% 0.62%
Capitalization / Revenue 0.97 x 0.54 x 0.79 x 0.96 x 1 x 1.46 x 4.2 x 3.64 x
EV / Revenue 1.26 x 0.8 x 1.27 x 1.4 x 1.44 x 1.94 x 3.89 x 3.3 x
EV / EBITDA 11.6 x 5.58 x 10.2 x 9.67 x 11 x 15.4 x 22.5 x 17.9 x
EV / FCF 629 x 10 x 9.11 x 17.3 x 15.4 x 35.9 x 76.5 x 36 x
FCF Yield 0.16% 9.97% 11% 5.79% 6.48% 2.78% 1.31% 2.78%
Price to Book 2.42 x 1.45 x 2.03 x 2.48 x 2.7 x 4.48 x 4.9 x 4.39 x
Nbr of stocks (in thousands) 501,523 496,509 496,509 497,170 497,280 497,370 - -
Reference price 2 154.2 95.15 137.4 197.5 240.7 364.0 364.0 364.0
Announcement Date 5/28/19 6/23/20 6/22/21 5/24/22 5/25/23 5/28/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 79,627 87,385 86,084 102,533 119,329 139,782 43,069 49,795
EBITDA 1 8,630 12,576 10,628 14,832 15,653 17,574 7,449 9,189
EBIT 1 5,566 6,717 4,452 8,427 7,848 7,696 4,827 6,227
Operating Margin 6.99% 7.69% 5.17% 8.22% 6.58% 5.51% 11.21% 12.51%
Earnings before Tax (EBT) 1 4,105 3,302 2,015 6,363 5,339 3,303 4,619 6,407
Net income 1 3,331 2,766 1,477 5,260 4,249 1,293 3,536 4,941
Net margin 4.18% 3.17% 1.72% 5.13% 3.56% 0.92% 8.21% 9.92%
EPS 2 6.620 5.500 2.970 10.57 8.530 2.600 32.25 10.28
Free Cash Flow 1 158.9 6,994 11,950 8,304 11,168 7,552 2,188 4,565
FCF margin 0.2% 8% 13.88% 8.1% 9.36% 5.4% 5.08% 9.17%
FCF Conversion (EBITDA) 1.84% 55.61% 112.44% 55.99% 71.35% 42.97% 29.37% 49.68%
FCF Conversion (Net income) 4.77% 252.84% 808.83% 157.88% 262.83% 584.17% 61.87% 92.38%
Dividend per Share 2 - - - - - 2.000 60.58 2.250
Announcement Date 5/28/19 6/23/20 6/22/21 5/24/22 5/25/23 5/28/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 22,589 23,909 23,716 25,043 26,496 27,278 26,621 28,163 31,921 32,623 32,154 32,654 35,540 37,184
EBITDA 1 3,279 3,211 2,808 3,428 3,971 4,625 2,921 3,189 4,487 5,056 3,877 4,162 4,895 5,592
EBIT 1 1,706 1,684 1,279 1,865 2,362 2,922 1,171 1,295 2,512 2,870 1,702 2,439 2,078 3,134
Operating Margin 7.55% 7.05% 5.39% 7.45% 8.91% 10.71% 4.4% 4.6% 7.87% 8.8% 5.29% 7.47% 5.85% 8.43%
Earnings before Tax (EBT) 1 1,142 1,215 - 1,342 1,808 2,519 856.1 707.5 1,724 2,050 805.6 1,388 1,118 2,129
Net income 1 924.2 1,054 - 1,069 1,483 2,263 685.4 462.1 1,394 1,708 49 942.7 696 1,748
Net margin 4.09% 4.41% - 4.27% 5.6% 8.29% 2.57% 1.64% 4.37% 5.23% 0.15% 2.89% 1.96% 4.7%
EPS 2 1.860 2.120 - 2.150 2.980 4.550 1.380 0.9300 2.800 3.430 0.1000 3.100 1.400 2.900
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 2/9/21 6/22/21 8/11/21 11/11/21 2/8/22 5/24/22 8/11/22 11/10/22 2/14/23 5/25/23 8/14/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 22,641 22,907 40,668 45,209 52,605 67,883 - -
Net Cash position 1 - - - - - - 13,619 16,652
Leverage (Debt/EBITDA) 2.623 x 1.821 x 3.827 x 3.048 x 3.361 x 3.863 x - -
Free Cash Flow 1 159 6,994 11,950 8,304 11,168 7,552 2,188 4,565
ROE (net income / shareholders' equity) 11% 8.53% 4.45% 14.4% 10.1% 2.87% 11.5% 14.5%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 63.60 65.50 67.90 79.50 89.10 91.30 74.30 83.00
Cash Flow per Share 2 11.60 24.30 31.50 26.40 36.70 31.20 11.50 15.80
Capex 1 5,677 5,239 3,742 4,830 7,172 7,969 4,299 3,881
Capex / Sales 7.13% 5.99% 4.35% 4.71% 6.01% 5.7% 9.98% 7.79%
Announcement Date 5/28/19 6/23/20 6/22/21 5/24/22 5/25/23 5/28/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Aster DM Healthcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
364 INR
Average target price
410.8 INR
Spread / Average Target
+12.88%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
ASTER DM HEALTHCARE LIMITED Stock Aster DM Healthcare Limited
-11.19% 2.17B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-23.39% 15.56B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-2.70% 11.65B
IHH HEALTHCARE Stock IHH Healthcare
+2.65% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+2.37% 10.06B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+29.48% 8.7B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-10.45% 7.16B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+8.05% 6.85B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
-4.29% 5.71B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-3.96% 4.3B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. ASTERDM Stock
  4. Financials Aster DM Healthcare Limited